semaglutide compounding news november 2025 September 15, 2025: Telehealth company must stop implying its compounded GLP-1 is FDA-approved, warns FDA – Partnership for Safe Medicines 🚨 FDA Moves to Permanently

Some weeks show small gains despite adherence

Side effects of GLP-1 therapy (nausea, loss of appetite, mild injection-site reactions) depend on the medication and individual response, not primarily on delivery method

It remains in Phase 3 clinical trials through the TRIUMPH program, which includes multiple studies examining different patient populations and endpoints

You can take Zepbound with or without food

Choose a clinician who will titrate slowly, monitor labs and symptoms, and plan cycles rather than indefinite use

The pill is likely to be cheaper than the injectables and one (not yet available in Europe) has been shown to help maintain weight loss after coming off injectables